Discontinued
Strength
.1 mg/mL
Manufacturer
Hospira Inc.NDC
00409493310
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Last Updated
4/22/2026
Active Ingredients
EPINEPHRINEApproval Type
New Drug (NDA)
FDA Application
NDA209359On Market Since
3/10/2021
Pharmacological Classes
Adrenergic alpha-Agonists
Adrenergic beta-Agonists
Catecholamine
Catecholamines
alpha-Adrenergic Agonist
beta-Adrenergic Agonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
RYNEX PSE LIQUID
Generic
00485020616•Edwards Pharmaceuticals, Inc.
$0.0364
per ML
SUDOGEST COLD AND ALLERGY TAB
Generic
00904535124•Major Pharmaceuticals
$0.0535
per EA
NASAL DECONGESTANT 30 MG TAB
Generic
36800043262•Topco Associates LLC
$0.0539
per EA
NASAL DECONGESTANT 30 MG TAB
Generic
36800043267•Topco Associates LLC
$0.0539
per EA
QC NASAL DECONGEST 30 MG TAB
Generic
63868080248•Chain Drug Marketing Association
$0.0553
per EA
LOHIST-D LIQUID
Generic
68047012016•Larken Laboratories, Inc.
$0.0587
per ML
SM NASAL DECONGEST 30 MG TAB
Generic
70677000501•Strategic Sourcing Services LLC
$0.0598
per EA
APRODINE TABLET
Generic
00904730224•Major Pharmaceuticals
$0.0611
per EA
APRODINE TABLET
Generic
00904730260•Major Pharmaceuticals
$0.0611
per EA
SM NASAL DECONGEST 30 MG TAB
Generic
70677000502•Strategic Sourcing Services LLC
$0.0641
per EA